3Worobol R, Kim BC, Kim S, et al. Detection of choleratoxin binding activity of glycomacropeptide from bovine casein and optimization of its production by use of response surface metho dology[J]. Dairy Foods, 1998,81: 28--31.
4Otain H, Hata I. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer patch cells by bovine milk caseins and their digests[J]. J Dairy Res, 1995, 62: 339--348.
6SylvieB, FlorenceL, MireilleY, et al. Effects of gastric digestive products from casein on CCK release by intestinal cells in rat [J]. J Nutr Biochem,1994, 5: 578--584.
7Gustafson DR, McMahon DJ, Moorrey J, et al.Appetite is not influenced by a unique milk peptide :caseinomacropeptide (CMP) [J]. Appetite, 2001, 36: 157--163.
8Britt M Burton-Freeman. Glycomacropeptide(GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK) [J]. Physiol Behav, 2008, 93: 379--387.
10TALBO G H, SUCKAU D, MALKOSKIA M, et al. MALDI-PSD-MS analysis of the phosphorylation sites of caseinomacropeptide[J]. Peptides, 2001, 22: 1093-1098.
1Waugh D F, Von Hippel P H. K-Casein and the stabilizationof casein micelles [J] . J. Am. Chem. Sot.,1956,78 (18):4 576-4 582.
2Delfour A,Jollis J,Alais C,et al. Caseino-glycopeptides:characterization of a methionine residue in the N -terminalsequence [J] . Biochem. Biophys. Res. Commun., 1965,19: 452-455.
3Abd El- Salam M H, El-Shibiny S,Buchheimh W. Char-acteristics and potential uses of the casein macropep -tide [J] . Int. Dairy J., 1996, 6 (4): 327-341.
4Pedersen N L, Nagain -Domaine C,Mahe S,et al,Caseinomacropeptide specifically stimulates exocrine pan-creatic secretion in the anes -thetized rat [ J] . Peptides,2000, 21: 1 527-1 535.
5Eigel W N,Buttler J E,Emstorm C A,et al. Nomencla-ture of proteins of cow's milk: Fifth revision [J] . J. DairySci., 1984,67 (8) : 1 599-1 631.
6Chabance B, Marteau P,Rambaud J C,et al. Caseinpeptide release and passage to the blood in humans duringdigestion of milk or yogurt [J] . Biochimie, 1998,80 (2):155-165.
7Van Calcar S C,Ney D M. Food products made withglycomacropeptide, a low phenylalanine whey protein,provide a new alternative to amino acid based medical foodsfor nutrition management of phenylketonuria [J] . J. Acad.Nutr. Diet., 2012,112 (8) : 1 201-1 210.
8Nielsen P, Tromholt N. Method for production of kappa-casein glyco -macropeptide and use of a kappa - caseinglycomacropeptide : World Patent, 9415952 [P] . 1994-10-04.
9Whitney R M. Proteins in milk [M] // Wong N P,JennessR, M Keeney, et al. Fundamentals of dairy chemistry.New York: Van Nostrand Reinhold, 1988: 89-92.
10Manso M A, Lopez-Fandino R. K-casein macropeptide fromcheese whey: physiochemical,biological, nutritional, andtechnological features for possible uses [J] . Food Rev. Int.,2004, 20: 339-355.
